Article ; Online: Arzneimitteltherapie von arterieller Hypertonie und Vorhofflimmern bei gebrechlichen Patienten : Gibt es neue Erkenntnisse und Empfehlungen?
Innere Medizin (Heidelberg, Germany)
2024 Volume 65, Issue 5, Page(s) 517–523
Abstract: The frail and elderly are considered to be at particular risk of suffering an adverse drug reaction. Empirical studies confirm the increased rate of adverse drug reactions. Whether frailty per se impairs drug metabolism or the underlying organ ageing ... ...
| Title translation | Drug therapy for arterial hypertension and atrial fibrillation in frail patients : Are there any new insights and recommendations? |
|---|---|
| Abstract | The frail and elderly are considered to be at particular risk of suffering an adverse drug reaction. Empirical studies confirm the increased rate of adverse drug reactions. Whether frailty per se impairs drug metabolism or the underlying organ ageing processes and multimorbidity cannot be answered with certainty based on current data. Cardiovascular diseases exhibit a considerable interdependence with frailty. For example, there is a disproportionate syndromal interdependence between heart failure and frailty, and the typical ageing processes of the sinus node can be interpreted as heartbeat frailty. Multimorbidity in the elderly often includes a cluster of chronic cardiovascular diseases, often leading to the use of several cardiovascular medications as required. More recent definitions of polypharmacy assess the appropriateness of drugs rather than their number. The Fit-fOR-The-Aged (FORTA) list, the PRISCUS 2.0 list and the "Cochrane Library Special Collection on deprescribing", for example, offer a practice-oriented assessment aid. In the treatment of arterial hypertension, the target values for older people have also been set ever lower in recent years. In the case of frail elderly people, on the other hand, the guidelines do not specify a strict blood pressure target corridor; tolerability is the crucial factor here. When initiating antihypertensive therapy in frail individuals, one can consider monotherapy-in a departure from the standard case of dual combination therapy. The OPTIMISE study showed that discontinuation of one blood pressure medication did not lead to better tolerability of the drug therapy. Current studies come to differing conclusions regarding the risk-benefit assessment of new oral anticoagulants compared to vitamin K antagonists in the anticoagulation of frail elderly people with atrial fibrillation. Shared decision-making, which could improve adherence particularly in older people, is recommended. |
| MeSH term(s) | Humans ; Atrial Fibrillation/drug therapy ; Atrial Fibrillation/complications ; Aged ; Frail Elderly ; Hypertension/drug therapy ; Aged, 80 and over ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/adverse effects ; Frailty ; Polypharmacy |
| Chemical Substances | Antihypertensive Agents |
| Language | German |
| Publishing date | 2024-03-08 |
| Publishing country | Germany |
| Document type | English Abstract ; Journal Article ; Review |
| ISSN | 2731-7099 |
| ISSN (online) | 2731-7099 |
| DOI | 10.1007/s00108-024-01681-8 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.